Results 231 to 240 of about 9,805,880 (332)

Approach to Glomerular Disease in Pregnancy. [PDF]

Indian J Nephrol
Meena P, Jesudason S, Popa CA, Rao NS, Priyamvada PS.   +4 more
europepmc   +1 more source

More Than a Question of Correlation: Characterization of the Evidentiary Basis for Biomarker Surrogates Used in European Marketing Authorizations

Clinical Pharmacology &Therapeutics, EarlyView.
Traditionally, clinical outcomes measuring how a patient feels, functions, or survives are preferred endpoints in clinical trials; however, some may take a long time to manifest in slowly developing diseases. Biomarkers, if properly validated, can serve as surrogate endpoints, acting as substitutes for clinical outcomes.
Renske Johanna Grupstra, Viktoriia Starokozhko, Elisabeth Bakker, Anna Maria Gerdina Pasmooij, Peter Gerardus Maria Mol   +4 more
wiley   +1 more source

Enhancing Patient Comprehension of Glomerular Disease Treatments Using ChatGPT. [PDF]

Healthcare (Basel)
Abdelgadir YH, Thongprayoon C, Craici IM, Cheungpasitporn W, Miao J.   +4 more
europepmc   +1 more source

Vascular Growth Factors and Glomerular Disease.

Annual Review of Physiology, 2016
Christina S Bartlett, M. Jeansson, S. Quaggin   +2 more
semanticscholar   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

Decoding Glomerular Disease: Baseline Profiles and Insights From the I-TANGIBLE Registry. [PDF]

Kidney Int Rep
Yadav K, Ramachandran R, Kumar V, Prabhahar A, Yadav AK, Gopalakrishnan N, Sharma S, P S P, Lahiri A, Sahay M, Raju SB, Sreelatha M, Manorajan R, Mukhopadhyay P, Prasad N, Veeranki V, Meena P, Kohli HS, Vikrant S, Jha V.   +19 more
europepmc   +1 more source

Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

ESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai, Minoru Yasukawa, Shigeru Shibata   +2 more
wiley   +1 more source

Varying mortality risks among patients with primary glomerular disease starting kidney replacement therapy: ERA Registry Figure of the month. [PDF]

Clin Kidney J
Stel VS, Ortiz A, Kramer A.
europepmc   +1 more source

The podocyte as a direct target for treatment of glomerular disease?

AJP - Renal Physiology, 2016
S. Mallipattu, J. He
semanticscholar   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source